세계의 수술 중 신경 모니터링 시장 규모, 점유율 및 동향 분석 보고서 : 소스 유형별, 최종 사용자별, 제품 및 서비스별, 용도별, 모달리티별, 지역별 전망 및 예측(2023-2030년)

The Global Intraoperative Neuromonitoring Market size is expected to reach $7 billion by 2030, rising at a market growth of 6.0% CAGR during the forecast period.

Orthopedic surgeons frequently perform spinal surgeries, including spinal fusions, laminectomies, and discectomies. In these procedures, this neuromonitoring is vital for assessing the integrity of neural structures such as the spinal cord and nerve roots, ensuring their preservation during instrumentation and fusion processes. Consequently, the orthopedic surgery segment would acquire nearly 20% of the total market share by 2030. Orthopedic surgeries related to joint replacements, such as hip and knee replacements, may involve monitoring peripheral nerves to avoid injury during implantation. IONM provides valuable feedback to surgeons, helping prevent nerve damage and postoperative complications.

The overall growth in surgical procedures, including neurosurgery, orthopedics, and cardiovascular surgeries, significantly drives the demand for this neuromonitoring. As surgical volumes rise globally, so does the need for techniques that ensure the safety of critical neural structures. The adoption of minimally invasive surgical techniques is expanding across various medical specialties. In minimally invasive procedures, where direct visualization may be limited, this neuromonitoring provides real-time feedback to surgeons, contributing to the growth of IONM. Hence, the market is expanding significantly due to the increasing surgical procedures. Additionally, advancements in electrode technology have led to the development of high-resolution electrodes capable of capturing detailed neural signals. These electrodes provide clearer and more precise information about the functional integrity of neural structures during surgery. Surgeons and healthcare professionals can utilize these devices in various surgical settings, including ambulatory surgical centers and outpatient facilities. Advanced signal processing algorithms enhance the accuracy of data interpretation. Therefore, technological advancements in neuromonitoring technologies have been a pivotal factor in driving the growth of the market.

However, Regulatory bodies often impose stringent requirements for medical devices and procedures, including IONM systems. Manufacturers may find it difficult and expensive to meet these standards, which may delay the introduction of innovative technology. Smaller companies with innovative IONM solutions may face challenges navigating complex regulatory processes. This can create barriers to entry into the market for smaller enterprises, limiting competition and potentially hindering technological advancements. Hence, regulatory compliance and standardization are a significant challenge that hampers the growth of market.

Moreover, the availability of medical equipment, particularly IONM devices and accessories, was impacted by disruptions in the global supply chain. This led to delays in the procurement and maintenance of IONM systems. Hospitals and healthcare facilities faced the challenge of reallocating resources to manage the surge in COVID-19 cases. This resulted in a change in focus, emphasizing critical and emergency surgeries, which may affect the use of IONM in elective or non-urgent procedures. Thus, the COVID-19 pandemic had a moderate effect on the market.

By Source Type Analysis

Based on source type, the market is bifurcated into insourced monitoring and outsourced monitoring. The outsourced monitoring segment acquired a substantial revenue share in the market in 2022. Outsourced monitoring offers scalability and flexibility in adjusting monitoring services based on demand. Healthcare institutions can scale up or down their neuromonitoring services as needed without the constraints of maintaining a fixed in-house team. Outsourced monitoring services offer rapid deployment and on-demand availability. This can be particularly beneficial for healthcare facilities requiring immediate access to neuromonitoring services without delays associated with internal setup.

By End User Analysis

Based on end user, the market is segmented into hospitals and ambulatory surgical centers (ASCs). The ambulatory surgical centers (ASCs) segment covered a considerable revenue share in the market in 2022. ASCs have experienced a steady rise in the volume of surgical procedures performed on an outpatient basis. As the demand for ambulatory surgery increases, so does the need for this neuromonitoring to enhance patient safety and surgical precision. ASCs prioritize patient-centric care, and integrating this neuromonitoring aligns with this focus. ASCs can provide advanced care alternatives in a patient-friendly environment by improving patient safety and lowering the risk of neurological problems. As ASCs increasingly adopt this neuromonitoring, surgeons and medical staff become more familiar with the technology. This familiarity fosters a positive environment for integrating IONM into a broader range of surgical procedures at ASCs.

By Products & Services Analysis

By products & services, the market is categorized into systems, accessories, and services. The accessories segment covered a considerable revenue share in the market in 2022. Specialized electrodes and sensors are crucial accessories in IONM. These components are directly applied to the patient to capture neural signals accurately. Advancements in electrode materials and designs contribute to improved signal quality and reduced interference, enhancing the overall reliability of IONM. Accessories that aid in precisely placing electrodes are essential for optimizing the monitoring process. These tools ensure accurate positioning, critical for obtaining reliable and meaningful neural data during surgery.

By Application Analysis

On the basis of application, the market is divided into spinal surgery, neurosurgery, orthopedic surgery, ENT surgery, vascular surgery, and others. The neurosurgery segment garnered a significant revenue share in the market in 2022. Neurosurgery involves highly intricate procedures within the brain and spinal cord. The complexity of these interventions necessitates precise monitoring of neural structures to avoid damage and ensure optimal outcomes. IONM provides real-time feedback to surgeons during neurosurgical procedures. Advances in neurosurgical techniques, including minimally invasive procedures and image-guided surgeries, are complemented by the integration of this neuromonitoring. The combined use of these technologies enhances the precision and safety of neurosurgical interventions.

By Modality Analysis

By modality, the market is classified into motor evoked potentials (MEPs), somatosensory evoked potentials (SSEPs), electroencephalography (EEG), electromyography (EMG), brainstem auditory evoked potentials (BAEPs), and visual evoked potentials (VEPs). The electroencephalography (EEG) segment recorded a remarkable revenue share in the market in 2022. EEG is a valuable tool for monitoring brain function in real time. During surgeries, especially those involving the brain or procedures that may impact cerebral blood flow, EEG provides continuous feedback on the brain's electrical activity. EEG monitoring is extensively used in neurosurgical procedures, including brain tumor resections and epilepsy surgeries. Monitoring the EEG helps surgeons navigate critical brain regions and identify abnormal patterns, contributing to the success of these delicate procedures. EEG plays a crucial role in surgeries related to epilepsy, where precise localization of the epileptic focus is essential. Continuous EEG monitoring assists in identifying seizure activity and guides respective surgery or other interventions.

By Regional Analysis

Region-wise, the market is analysed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the North America region led the market by generating the highest revenue share. North America boasts an advanced healthcare infrastructure with well-established medical facilities, research centers, and hospitals. The North American region witnesses a significant number of spinal surgeries, including procedures for degenerative spine conditions, herniated discs, and spinal fusions. The region experiences many orthopedic procedures, including joint replacements and complex orthopedic surgeries. The aging population in North America contributes to a higher demand for surgical interventions, particularly in neurosurgery and orthopedics.

List of Key Companies Profiled

• Nihon Kohden Corporation
• inomed Medizintechnik GmbH
• Medtronic PLC
• SpecialtyCare, Inc. (Morgan Stanley)
• NeuroStyle Pte. Ltd.
• Computational Diagnostics, Inc.
• Accurate Neuromonitoring, LLC (Housatonic Partners)
• Intranerve Neuroscience Holdings, Llc
• Natus Medical Incorporated (Archimed SAS)
• Globus Medical, Inc.

Global Intraoperative Neuromonitoring Market Report Segmentation

By Source Type

• Insourced Monitoring
• Outsourced Monitoring

By End User

• Hospitals
• Ambulatory Surgical Centers (ASCs)

By Products & Services

• Services
• Systems
• Accessories

By Application

• Spinal Surgery
• Neurosurgery
• Orthopedic Surgery
• ENT Surgery
• Vascular Surgery
• Others

By Modality

• Electromyography (EMG)
• Electroencephalography (EEG)
• Motor Evoked Potentials (MEPs)
• Somatosensory Evoked Potentials (SSEPs)
• Visual Evoked Potentials (VEPs)
• Brainstem Auditory Evoked Potentials (BAEPs)

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Table of Contents

Chapter 1. Market Scope & Methodology

• 1.1 Market Definition
• 1.2 Objectives
• 1.3 Market Scope
• 1.4 Segmentation
  • 1.4.1 Global Intraoperative Neuromonitoring Market, by Source Type
  • 1.4.2 Global Intraoperative Neuromonitoring Market, by End User
  • 1.4.3 Global Intraoperative Neuromonitoring Market, by Products & Services
  • 1.4.4 Global Intraoperative Neuromonitoring Market, by Application
  • 1.4.5 Global Intraoperative Neuromonitoring Market, by Modality
  • 1.4.6 Global Intraoperative Neuromonitoring Market, by Geography
• 1.5 Methodology for the research

Chapter 2. Market at a Glance

• 2.1 Key Highlights

Chapter 3. Market Overview

• 3.1 Introduction
  • 3.1.1 Overview
    • 3.1.1.1 Market Composition and Scenario
• 3.2 Key Factors Impacting the Market
  • 3.2.1 Market Drivers
  • 3.2.2 Market Restraints
• 3.3 Porter Five Forces Analysis

Chapter 4. Global Intraoperative Neuromonitoring Market by Source Type

• 4.1 Global Insourced Monitoring Market by Region
• 4.2 Global Outsourced Monitoring Market by Region

Chapter 5. Global Intraoperative Neuromonitoring Market by End User

• 5.1 Global Hospitals Market by Region
• 5.2 Global Ambulatory Surgical Centers (ASCs) Market by Region

Chapter 6. Global Intraoperative Neuromonitoring Market by Products & Services

• 6.1 Global Services Market by Region
• 6.2 Global Systems Market by Region
• 6.3 Global Accessories Market by Region

Chapter 7. Global Intraoperative Neuromonitoring Market by Application

• 7.1 Global Spinal Surgery Market by Region
• 7.2 Global Neurosurgery Market by Region
• 7.3 Global Orthopedic Surgery Market by Region
• 7.4 Global ENT Surgery Market by Region
• 7.5 Global Vascular Surgery Market by Region
• 7.6 Global Others Market by Region

Chapter 8. Global Intraoperative Neuromonitoring Market by Modality

• 8.1 Global Electromyography (EMG) Market by Region
• 8.2 Global Electroencephalography (EEG) Market by Region
• 8.3 Global Motor Evoked Potentials (MEPs) Market by Region
• 8.4 Global Somatosensory Evoked Potentials (SSEPs) Market by Region
• 8.5 Global Visual Evoked Potentials (VEPs) Market by Region
• 8.6 Global Brainstem Auditory Evoked Potentials (BAEPs) Market by Region

Chapter 9. Global Intraoperative Neuromonitoring Market by Region

• 9.1 North America Intraoperative Neuromonitoring Market
  • 9.1.1 North America Intraoperative Neuromonitoring Market by Source Type
    • 9.1.1.1 North America Insourced Monitoring Market by Region
    • 9.1.1.2 North America Outsourced Monitoring Market by Region
  • 9.1.2 North America Intraoperative Neuromonitoring Market by End User
    • 9.1.2.1 North America Hospitals Market by Region
    • 9.1.2.2 North America Ambulatory Surgical Centers (ASCs) Market by Region
  • 9.1.3 North America Intraoperative Neuromonitoring Market by Products & Services
    • 9.1.3.1 North America Services Market by Country
    • 9.1.3.2 North America Systems Market by Country
    • 9.1.3.3 North America Accessories Market by Country
  • 9.1.4 North America Intraoperative Neuromonitoring Market by Application
    • 9.1.4.1 North America Spinal Surgery Market by Country
    • 9.1.4.2 North America Neurosurgery Market by Country
    • 9.1.4.3 North America Orthopedic Surgery Market by Country
    • 9.1.4.4 North America ENT Surgery Market by Country
    • 9.1.4.5 North America Vascular Surgery Market by Country
    • 9.1.4.6 North America Others Market by Country
  • 9.1.5 North America Intraoperative Neuromonitoring Market by Modality
    • 9.1.5.1 North America Electromyography (EMG) Market by Country
    • 9.1.5.2 North America Electroencephalography (EEG) Market by Country
    • 9.1.5.3 North America Motor Evoked Potentials (MEPs) Market by Country
    • 9.1.5.4 North America Somatosensory Evoked Potentials (SSEPs) Market by Country
    • 9.1.5.5 North America Visual Evoked Potentials (VEPs) Market by Country
    • 9.1.5.6 North America Brainstem Auditory Evoked Potentials (BAEPs) Market by Country
  • 9.1.6 North America Intraoperative Neuromonitoring Market by Country
    • 9.1.6.1 US Intraoperative Neuromonitoring Market
      • 9.1.6.1.1 US Intraoperative Neuromonitoring Market by Source Type
      • 9.1.6.1.2 US Intraoperative Neuromonitoring Market by End User
      • 9.1.6.1.3 US Intraoperative Neuromonitoring Market by Products & Services
      • 9.1.6.1.4 US Intraoperative Neuromonitoring Market by Application
      • 9.1.6.1.5 US Intraoperative Neuromonitoring Market by Modality
    • 9.1.6.2 Canada Intraoperative Neuromonitoring Market
      • 9.1.6.2.1 Canada Intraoperative Neuromonitoring Market by Source Type
      • 9.1.6.2.2 Canada Intraoperative Neuromonitoring Market by End User
      • 9.1.6.2.3 Canada Intraoperative Neuromonitoring Market by Products & Services
      • 9.1.6.2.4 Canada Intraoperative Neuromonitoring Market by Application
      • 9.1.6.2.5 Canada Intraoperative Neuromonitoring Market by Modality
    • 9.1.6.3 Mexico Intraoperative Neuromonitoring Market
      • 9.1.6.3.1 Mexico Intraoperative Neuromonitoring Market by Source Type
      • 9.1.6.3.2 Mexico Intraoperative Neuromonitoring Market by End User
      • 9.1.6.3.3 Mexico Intraoperative Neuromonitoring Market by Products & Services
      • 9.1.6.3.4 Mexico Intraoperative Neuromonitoring Market by Application
      • 9.1.6.3.5 Mexico Intraoperative Neuromonitoring Market by Modality
    • 9.1.6.4 Rest of North America Intraoperative Neuromonitoring Market
      • 9.1.6.4.1 Rest of North America Intraoperative Neuromonitoring Market by Source Type
      • 9.1.6.4.2 Rest of North America Intraoperative Neuromonitoring Market by End User
      • 9.1.6.4.3 Rest of North America Intraoperative Neuromonitoring Market by Products & Services
      • 9.1.6.4.4 Rest of North America Intraoperative Neuromonitoring Market by Application
      • 9.1.6.4.5 Rest of North America Intraoperative Neuromonitoring Market by Modality
• 9.2 Europe Intraoperative Neuromonitoring Market
  • 9.2.1 Europe Intraoperative Neuromonitoring Market by Source Type
    • 9.2.1.1 Europe Insourced Monitoring Market by Country
    • 9.2.1.2 Europe Outsourced Monitoring Market by Country
  • 9.2.2 Europe Intraoperative Neuromonitoring Market by End User
    • 9.2.2.1 Europe Hospitals Market by Country
    • 9.2.2.2 Europe Ambulatory Surgical Centers (ASCs) Market by Country
  • 9.2.3 Europe Intraoperative Neuromonitoring Market by Products & Services
    • 9.2.3.1 Europe Services Market by Country
    • 9.2.3.2 Europe Systems Market by Country
    • 9.2.3.3 Europe Accessories Market by Country
  • 9.2.4 Europe Intraoperative Neuromonitoring Market by Application
    • 9.2.4.1 Europe Spinal Surgery Market by Country
    • 9.2.4.2 Europe Neurosurgery Market by Country
    • 9.2.4.3 Europe Orthopedic Surgery Market by Country
    • 9.2.4.4 Europe ENT Surgery Market by Country
    • 9.2.4.5 Europe Vascular Surgery Market by Country
    • 9.2.4.6 Europe Others Market by Country
  • 9.2.5 Europe Intraoperative Neuromonitoring Market by Modality
    • 9.2.5.1 Europe Electromyography (EMG) Market by Country
    • 9.2.5.2 Europe Electroencephalography (EEG) Market by Country
    • 9.2.5.3 Europe Motor Evoked Potentials (MEPs) Market by Country
    • 9.2.5.4 Europe Somatosensory Evoked Potentials (SSEPs) Market by Country
    • 9.2.5.5 Europe Visual Evoked Potentials (VEPs) Market by Country
    • 9.2.5.6 Europe Brainstem Auditory Evoked Potentials (BAEPs) Market by Country
  • 9.2.6 Europe Intraoperative Neuromonitoring Market by Country
    • 9.2.6.1 Germany Intraoperative Neuromonitoring Market
      • 9.2.6.1.1 Germany Intraoperative Neuromonitoring Market by Source Type
      • 9.2.6.1.2 Germany Intraoperative Neuromonitoring Market by End User
      • 9.2.6.1.3 Germany Intraoperative Neuromonitoring Market by Products & Services
      • 9.2.6.1.4 Germany Intraoperative Neuromonitoring Market by Application
      • 9.2.6.1.5 Germany Intraoperative Neuromonitoring Market by Modality
    • 9.2.6.2 UK Intraoperative Neuromonitoring Market
      • 9.2.6.2.1 UK Intraoperative Neuromonitoring Market by Source Type
      • 9.2.6.2.2 UK Intraoperative Neuromonitoring Market by End User
      • 9.2.6.2.3 UK Intraoperative Neuromonitoring Market by Products & Services
      • 9.2.6.2.4 UK Intraoperative Neuromonitoring Market by Application
      • 9.2.6.2.5 UK Intraoperative Neuromonitoring Market by Modality
    • 9.2.6.3 France Intraoperative Neuromonitoring Market
      • 9.2.6.3.1 France Intraoperative Neuromonitoring Market by Source Type
      • 9.2.6.3.2 France Intraoperative Neuromonitoring Market by End User
      • 9.2.6.3.3 France Intraoperative Neuromonitoring Market by Products & Services
      • 9.2.6.3.4 France Intraoperative Neuromonitoring Market by Application
      • 9.2.6.3.5 France Intraoperative Neuromonitoring Market by Modality
    • 9.2.6.4 Russia Intraoperative Neuromonitoring Market
      • 9.2.6.4.1 Russia Intraoperative Neuromonitoring Market by Source Type
      • 9.2.6.4.2 Russia Intraoperative Neuromonitoring Market by End User
      • 9.2.6.4.3 Russia Intraoperative Neuromonitoring Market by Products & Services
      • 9.2.6.4.4 Russia Intraoperative Neuromonitoring Market by Application
      • 9.2.6.4.5 Russia Intraoperative Neuromonitoring Market by Modality
    • 9.2.6.5 Spain Intraoperative Neuromonitoring Market
      • 9.2.6.5.1 Spain Intraoperative Neuromonitoring Market by Source Type
      • 9.2.6.5.2 Spain Intraoperative Neuromonitoring Market by End User
      • 9.2.6.5.3 Spain Intraoperative Neuromonitoring Market by Products & Services
      • 9.2.6.5.4 Spain Intraoperative Neuromonitoring Market by Application
      • 9.2.6.5.5 Spain Intraoperative Neuromonitoring Market by Modality
    • 9.2.6.6 Italy Intraoperative Neuromonitoring Market
      • 9.2.6.6.1 Italy Intraoperative Neuromonitoring Market by Source Type
      • 9.2.6.6.2 Italy Intraoperative Neuromonitoring Market by End User
      • 9.2.6.6.3 Italy Intraoperative Neuromonitoring Market by Products & Services
      • 9.2.6.6.4 Italy Intraoperative Neuromonitoring Market by Application
      • 9.2.6.6.5 Italy Intraoperative Neuromonitoring Market by Modality
    • 9.2.6.7 Rest of Europe Intraoperative Neuromonitoring Market
      • 9.2.6.7.1 Rest of Europe Intraoperative Neuromonitoring Market by Source Type
      • 9.2.6.7.2 Rest of Europe Intraoperative Neuromonitoring Market by End User
      • 9.2.6.7.3 Rest of Europe Intraoperative Neuromonitoring Market by Products & Services
      • 9.2.6.7.4 Rest of Europe Intraoperative Neuromonitoring Market by Application
      • 9.2.6.7.5 Rest of Europe Intraoperative Neuromonitoring Market by Modality
• 9.3 Asia Pacific Intraoperative Neuromonitoring Market
  • 9.3.1 Asia Pacific Intraoperative Neuromonitoring Market by Source Type
    • 9.3.1.1 Asia Pacific Insourced Monitoring Market by Country
    • 9.3.1.2 Asia Pacific Outsourced Monitoring Market by Country
  • 9.3.2 Asia Pacific Intraoperative Neuromonitoring Market by End User
    • 9.3.2.1 Asia Pacific Hospitals Market by Country
    • 9.3.2.2 Asia Pacific Ambulatory Surgical Centers (ASCs) Market by Country
  • 9.3.3 Asia Pacific Intraoperative Neuromonitoring Market by Products & Services
    • 9.3.3.1 Asia Pacific Services Market by Country
    • 9.3.3.2 Asia Pacific Systems Market by Country
    • 9.3.3.3 Asia Pacific Accessories Market by Country
  • 9.3.4 Asia Pacific Intraoperative Neuromonitoring Market by Application
    • 9.3.4.1 Asia Pacific Spinal Surgery Market by Country
    • 9.3.4.2 Asia Pacific Neurosurgery Market by Country
    • 9.3.4.3 Asia Pacific Orthopedic Surgery Market by Country
    • 9.3.4.4 Asia Pacific ENT Surgery Market by Country
    • 9.3.4.5 Asia Pacific Vascular Surgery Market by Country
    • 9.3.4.6 Asia Pacific Others Market by Country
  • 9.3.5 Asia Pacific Intraoperative Neuromonitoring Market by Modality
    • 9.3.5.1 Asia Pacific Electromyography (EMG) Market by Country
    • 9.3.5.2 Asia Pacific Electroencephalography (EEG) Market by Country
    • 9.3.5.3 Asia Pacific Motor Evoked Potentials (MEPs) Market by Country
    • 9.3.5.4 Asia Pacific Somatosensory Evoked Potentials (SSEPs) Market by Country
    • 9.3.5.5 Asia Pacific Visual Evoked Potentials (VEPs) Market by Country
    • 9.3.5.6 Asia Pacific Brainstem Auditory Evoked Potentials (BAEPs) Market by Country
  • 9.3.6 Asia Pacific Intraoperative Neuromonitoring Market by Country
    • 9.3.6.1 China Intraoperative Neuromonitoring Market
      • 9.3.6.1.1 China Intraoperative Neuromonitoring Market by Source Type
      • 9.3.6.1.2 China Intraoperative Neuromonitoring Market by End User
      • 9.3.6.1.3 China Intraoperative Neuromonitoring Market by Products & Services
      • 9.3.6.1.4 China Intraoperative Neuromonitoring Market by Application
      • 9.3.6.1.5 China Intraoperative Neuromonitoring Market by Modality
    • 9.3.6.2 Japan Intraoperative Neuromonitoring Market
      • 9.3.6.2.1 Japan Intraoperative Neuromonitoring Market by Source Type
      • 9.3.6.2.2 Japan Intraoperative Neuromonitoring Market by End User
      • 9.3.6.2.3 Japan Intraoperative Neuromonitoring Market by Products & Services
      • 9.3.6.2.4 Japan Intraoperative Neuromonitoring Market by Application
      • 9.3.6.2.5 Japan Intraoperative Neuromonitoring Market by Modality
    • 9.3.6.3 India Intraoperative Neuromonitoring Market
      • 9.3.6.3.1 India Intraoperative Neuromonitoring Market by Source Type
      • 9.3.6.3.2 India Intraoperative Neuromonitoring Market by End User
      • 9.3.6.3.3 India Intraoperative Neuromonitoring Market by Products & Services
      • 9.3.6.3.4 India Intraoperative Neuromonitoring Market by Application
      • 9.3.6.3.5 India Intraoperative Neuromonitoring Market by Modality
    • 9.3.6.4 South Korea Intraoperative Neuromonitoring Market
      • 9.3.6.4.1 South Korea Intraoperative Neuromonitoring Market by Source Type
      • 9.3.6.4.2 South Korea Intraoperative Neuromonitoring Market by End User
      • 9.3.6.4.3 South Korea Intraoperative Neuromonitoring Market by Products & Services
      • 9.3.6.4.4 South Korea Intraoperative Neuromonitoring Market by Application
      • 9.3.6.4.5 South Korea Intraoperative Neuromonitoring Market by Modality
    • 9.3.6.5 Singapore Intraoperative Neuromonitoring Market
      • 9.3.6.5.1 Singapore Intraoperative Neuromonitoring Market by Source Type
      • 9.3.6.5.2 Singapore Intraoperative Neuromonitoring Market by End User
      • 9.3.6.5.3 Singapore Intraoperative Neuromonitoring Market by Products & Services
      • 9.3.6.5.4 Singapore Intraoperative Neuromonitoring Market by Application
      • 9.3.6.5.5 Singapore Intraoperative Neuromonitoring Market by Modality
    • 9.3.6.6 Malaysia Intraoperative Neuromonitoring Market
      • 9.3.6.6.1 Malaysia Intraoperative Neuromonitoring Market by Source Type
      • 9.3.6.6.2 Malaysia Intraoperative Neuromonitoring Market by End User
      • 9.3.6.6.3 Malaysia Intraoperative Neuromonitoring Market by Products & Services
      • 9.3.6.6.4 Malaysia Intraoperative Neuromonitoring Market by Application
      • 9.3.6.6.5 Malaysia Intraoperative Neuromonitoring Market by Modality
    • 9.3.6.7 Rest of Asia Pacific Intraoperative Neuromonitoring Market
      • 9.3.6.7.1 Rest of Asia Pacific Intraoperative Neuromonitoring Market by Source Type
      • 9.3.6.7.2 Rest of Asia Pacific Intraoperative Neuromonitoring Market by End User
      • 9.3.6.7.3 Rest of Asia Pacific Intraoperative Neuromonitoring Market by Products & Services
      • 9.3.6.7.4 Rest of Asia Pacific Intraoperative Neuromonitoring Market by Application
      • 9.3.6.7.5 Rest of Asia Pacific Intraoperative Neuromonitoring Market by Modality
• 9.4 LAMEA Intraoperative Neuromonitoring Market
  • 9.4.1 LAMEA Intraoperative Neuromonitoring Market by Source Type
    • 9.4.1.1 LAMEA Insourced Monitoring Market by Country
    • 9.4.1.2 LAMEA Outsourced Monitoring Market by Country
  • 9.4.2 LAMEA Intraoperative Neuromonitoring Market by End User
    • 9.4.2.1 LAMEA Hospitals Market by Country
    • 9.4.2.2 LAMEA Ambulatory Surgical Centers (ASCs) Market by Country
  • 9.4.3 LAMEA Intraoperative Neuromonitoring Market by Products & Services
    • 9.4.3.1 LAMEA Services Market by Country
    • 9.4.3.2 LAMEA Systems Market by Country
    • 9.4.3.3 LAMEA Accessories Market by Country
  • 9.4.4 LAMEA Intraoperative Neuromonitoring Market by Application
    • 9.4.4.1 LAMEA Spinal Surgery Market by Country
    • 9.4.4.2 LAMEA Neurosurgery Market by Country
    • 9.4.4.3 LAMEA Orthopedic Surgery Market by Country
    • 9.4.4.4 LAMEA ENT Surgery Market by Country
    • 9.4.4.5 LAMEA Vascular Surgery Market by Country
    • 9.4.4.6 LAMEA Others Market by Country
  • 9.4.5 LAMEA Intraoperative Neuromonitoring Market by Modality
    • 9.4.5.1 LAMEA Electromyography (EMG) Market by Country
    • 9.4.5.2 LAMEA Electroencephalography (EEG) Market by Country
    • 9.4.5.3 LAMEA Motor Evoked Potentials (MEPs) Market by Country
    • 9.4.5.4 LAMEA Somatosensory Evoked Potentials (SSEPs) Market by Country
    • 9.4.5.5 LAMEA Visual Evoked Potentials (VEPs) Market by Country
    • 9.4.5.6 LAMEA Brainstem Auditory Evoked Potentials (BAEPs) Market by Country
  • 9.4.6 LAMEA Intraoperative Neuromonitoring Market by Country
    • 9.4.6.1 Brazil Intraoperative Neuromonitoring Market
      • 9.4.6.1.1 Brazil Intraoperative Neuromonitoring Market by Source Type
      • 9.4.6.1.2 Brazil Intraoperative Neuromonitoring Market by End User
      • 9.4.6.1.3 Brazil Intraoperative Neuromonitoring Market by Products & Services
      • 9.4.6.1.4 Brazil Intraoperative Neuromonitoring Market by Application
      • 9.4.6.1.5 Brazil Intraoperative Neuromonitoring Market by Modality
    • 9.4.6.2 Argentina Intraoperative Neuromonitoring Market
      • 9.4.6.2.1 Argentina Intraoperative Neuromonitoring Market by Source Type
      • 9.4.6.2.2 Argentina Intraoperative Neuromonitoring Market by End User
      • 9.4.6.2.3 Argentina Intraoperative Neuromonitoring Market by Products & Services
      • 9.4.6.2.4 Argentina Intraoperative Neuromonitoring Market by Application
      • 9.4.6.2.5 Argentina Intraoperative Neuromonitoring Market by Modality
    • 9.4.6.3 UAE Intraoperative Neuromonitoring Market
      • 9.4.6.3.1 UAE Intraoperative Neuromonitoring Market by Source Type
      • 9.4.6.3.2 UAE Intraoperative Neuromonitoring Market by End User
      • 9.4.6.3.3 UAE Intraoperative Neuromonitoring Market by Products & Services
      • 9.4.6.3.4 UAE Intraoperative Neuromonitoring Market by Application
      • 9.4.6.3.5 UAE Intraoperative Neuromonitoring Market by Modality
    • 9.4.6.4 Saudi Arabia Intraoperative Neuromonitoring Market
      • 9.4.6.4.1 Saudi Arabia Intraoperative Neuromonitoring Market by Source Type
      • 9.4.6.4.2 Saudi Arabia Intraoperative Neuromonitoring Market by End User
      • 9.4.6.4.3 Saudi Arabia Intraoperative Neuromonitoring Market by Products & Services
      • 9.4.6.4.4 Saudi Arabia Intraoperative Neuromonitoring Market by Application
      • 9.4.6.4.5 Saudi Arabia Intraoperative Neuromonitoring Market by Modality
    • 9.4.6.5 South Africa Intraoperative Neuromonitoring Market
      • 9.4.6.5.1 South Africa Intraoperative Neuromonitoring Market by Source Type
      • 9.4.6.5.2 South Africa Intraoperative Neuromonitoring Market by End User
      • 9.4.6.5.3 South Africa Intraoperative Neuromonitoring Market by Products & Services
      • 9.4.6.5.4 South Africa Intraoperative Neuromonitoring Market by Application
      • 9.4.6.5.5 South Africa Intraoperative Neuromonitoring Market by Modality
    • 9.4.6.6 Nigeria Intraoperative Neuromonitoring Market
      • 9.4.6.6.1 Nigeria Intraoperative Neuromonitoring Market by Source Type
      • 9.4.6.6.2 Nigeria Intraoperative Neuromonitoring Market by End User
      • 9.4.6.6.3 Nigeria Intraoperative Neuromonitoring Market by Products & Services
      • 9.4.6.6.4 Nigeria Intraoperative Neuromonitoring Market by Application
      • 9.4.6.6.5 Nigeria Intraoperative Neuromonitoring Market by Modality
    • 9.4.6.7 Rest of LAMEA Intraoperative Neuromonitoring Market
      • 9.4.6.7.1 Rest of LAMEA Intraoperative Neuromonitoring Market by Source Type
      • 9.4.6.7.2 Rest of LAMEA Intraoperative Neuromonitoring Market by End User
      • 9.4.6.7.3 Rest of LAMEA Intraoperative Neuromonitoring Market by Products & Services
      • 9.4.6.7.4 Rest of LAMEA Intraoperative Neuromonitoring Market by Application
      • 9.4.6.7.5 Rest of LAMEA Intraoperative Neuromonitoring Market by Modality

Chapter 10. Company Profiles

• 10.1 inomed Medizintechnik GmbH
  • 10.1.1 Company Overview
• 10.2 NeuroStyle Pte. Ltd.
  • 10.2.1 Company Overview
• 10.3 Computational Diagnostics, Inc.
  • 10.3.1 Company Overview
  • 10.3.2 SWOT Analysis
• 10.4 Accurate Neuromonitoring, LLC (Housatonic Partners)
  • 10.4.1 Company Overview
• 10.5 Medtronic PLC
  • 10.5.1 Company overview
  • 10.5.2 Financial Analysis
  • 10.5.3 Segmental and Regional Analysis
  • 10.5.4 Research & Development Expenses
  • 10.5.5 Recent strategies and developments:
    • 10.5.5.1 Trials and Approvals:
  • 10.5.6 SWOT Analysis
• 10.6 SpecialtyCare, Inc. (Morgan Stanley)
  • 10.6.1 Company Overview
  • 10.6.2 Financial Analysis
  • 10.6.3 Segmental and Regional Analysis
  • 10.6.4 Recent strategies and developments:
    • 10.6.4.1 Acquisition and Mergers:
• 10.7 IntraNerve Neuroscience Holdings, LLC
  • 10.7.1 Company Overview
• 10.8 Natus Medical Incorporated (Archimed SAS)
  • 10.8.1 Company Overview
  • 10.8.2 Recent strategies and developments:
    • 10.8.2.1 Acquisition and Mergers:
• 10.9 Globus Medical, Inc.
  • 10.9.1 Company Overview
  • 10.9.2 Financial Analysis
  • 10.9.3 Regional Analysis
  • 10.9.4 Research & Development Expense
  • 10.9.5 SWOT Analysis
• 10.10. Nihon Kohden Corporation
  • 10.10.1 Company Overview
  • 10.10.2 Financial Analysis
  • 10.10.3 Product Category and Regional Analysis
  • 10.10.4 Research & Development Expenses
  • 10.10.5 Recent strategies and developments:
    • 10.10.5.1 Product Launches and Product Expansions:
  • 10.10.6 SWOT Analysis

Chapter 11. Winning Imperatives for Intraoperative Neuromonitoring Market